C3 and hemolytic-uremic syndrome: In the International Registry of Recurrent and Familial HUS [1], for instance, ~ 45% of the individuals who were affected by primary aHUS and ~ 30% who were affected by secondary aHUS were found to carry a pathogenic variant in a number of the proteins that sustain or regulate C3b-dependent C5b-9 deposition [1].